Diabetes mellitus and risk of prostate cancer: an updated meta-analysis based on 12 case-control and 25 cohort studies. (Q53108925)

11 May 2018

meta-analysis

0 references

title

Diabetes mellitus and risk of prostate cancer: an updated meta-analysis based on 12 case-control and 25 cohort studies. (English)

1 reference

11 May 2018

author name string

Fan Zhang

1

1 reference

11 May 2018

Yuan Yang

2

1 reference

11 May 2018

Laura Skrip

3

1 reference

11 May 2018

Dayi Hu

4

1 reference

11 May 2018

Yang Wang

5

1 reference

11 May 2018

Chunguang Wong

6

1 reference

11 May 2018

Jingfu Qiu

7

1 reference

11 May 2018

Han Lei

8

1 reference

11 May 2018

publication date

4 November 2012

1 reference

11 May 2018

published in

Acta Diabetologica

1 reference

11 May 2018

volume

49 Suppl 1

1 reference

11 May 2018

page(s)

S235-46

1 reference

11 May 2018

https://scigraph.springernature.com/pub.10.1007/s00592-012-0439-5

exact match

0 references

cites work

Diabetes mellitus and the incidence of colorectal cancer: an updated systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

Epidemiological aspects of neoplasms in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

Diabetes mellitus and risk of prostate cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

A prospective Swedish study on body size, body composition, diabetes, and prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

Components of the metabolic syndrome and risk of prostate cancer: the HUNT 2 cohort, Norway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

Diabetes and risk of prostate cancer: a study using the National Health Insurance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

Diabetes and risk of incident cancer: a large population-based cohort study in Israel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

The association of diabetes and positive prostate biopsy in a US veteran population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

Risk factors for prostate cancer: An hospital-based case-control study from Mumbai, India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

The metabolic syndrome and risk of prostate cancer in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

Association of diabetes mellitus with prostate cancer: nested case-control study (Prostate testing for cancer and treatment study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

The protective effect of diabetes mellitus against prostate cancer: role of sex hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

Diabetes mellitus and prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

Time-varying incidence of cancer after the onset of type 2 diabetes: evidence of potential detection bias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

The effects of metabolic conditions on prostate cancer incidence over 15 years of follow-up: results from the Olmsted County Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

The metabolic syndrome and the risk of prostate cancer under competing risks of death from other causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

Risk of cancer in a large cohort of U.S. veterans with diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

Association of diabetes with prostate cancer risk in the multiethnic cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

Diabetes mellitus and risk of prostate cancer in the health professionals follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

Glycemic status and risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

Diabetes and the risk of prostate cancer: the role of diabetes treatment and complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

The metabolic syndrome is associated with reduced risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

Metformin and reduced risk of cancer in diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

The influence of antidiabetic medications on the development and progression of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

Cancer risk associated with insulin glargine among adult type 2 diabetes patients--a nationwide cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

Insulin analogues display IGF-I-like mitogenic and anti-apoptotic activities in cultured cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

Systematic review and meta-analysis methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

Operating characteristics of a rank correlation test for publication bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

History of diabetes mellitus and risk of prostate cancer in physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

Diabetes and the risk of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

Diabetes mellitus and the risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

Reduced risk of prostate cancer among patients with diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

Diabetes mellitus and risk of prostate cancer (United States).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

Post-challenge glucose concentration, impaired glucose tolerance, diabetes, and cancer mortality in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

Cigarette smoking as a predictor of death from prostate cancer in 348,874 men screened for the Multiple Risk Factor Intervention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

Prospective study of sex hormone levels and risk of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

Type 2 diabetes mellitus and testosterone: a meta-analysis study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

The role of IGF-1 resistance in obesity and type 2 diabetes-mellitus-related insulin resistance and vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

Insulin-Like Growth Factors (IGFs), IGF Receptors, and IGF-Binding Proteins in Primary Cultures of Prostate Epithelial Cells*

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

Circulating insulin-like growth factor peptides and prostate cancer risk: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

Prostate cancer risk and serum levels of insulin and leptin: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

Insulin resistance/hyperinsulinemia and cancer mortality: the Cremona study at the 15th year of follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

Synergistic effects of low LDL cholesterol with other factors for the risk of cancer in type 2 diabetes: the Hong Kong Diabetes Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

Diabetes Mellitus and the Risk of Prostate Cancer in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

Diabetes and Risk of Prostate Cancer in a Prospective Cohort of US Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

Obesity, Diabetes, and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

Intensive glycaemic control and cancer risk in type 2 diabetes: a meta-analysis of major trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0439-5

10.1007/S00592-012-0439-5

21 January 2018

Identifiers

DOI

1 reference

11 May 2018

1 reference

11 May 2018